Literature DB >> 25696075

Vitamins C. E and β-carotene fired and statins for president?

J W Jukema, A H Liem.   

Abstract

Entities:  

Year:  2002        PMID： 25696075      PMCID： PMC2499693     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  5 in total

Review 1.  Tailored therapy to fit individual profiles. Genetics and coronary artery disease.

Authors:  J W Jukema; J J Kastelein
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

2.  The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.

Authors:  J A Kuivenhoven; J W Jukema; A H Zwinderman; P de Knijff; R McPherson; A V Bruschke; K I Lie; J J Kastelein
Journal:  N Engl J Med       Date:  1998-01-08       Impact factor: 91.245

Review 3.  [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO].

Authors:  M L Simoons; A F Casparie
Journal:  Ned Tijdschr Geneeskd       Date:  1998-09-19

4.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

5.  Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).

Authors:  J W Jukema; A V Bruschke; A J van Boven; J H Reiber; E T Bal; A H Zwinderman; H Jansen; G J Boerma; F M van Rappard; K I Lie
Journal:  Circulation       Date:  1995-05-15       Impact factor: 29.690
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.